Reduced LDL receptor expression and LDL uptake in lymphoblastoid cells from a patient with cholesteryl ester storage disease.

Authors

Maëlle Jan, Marie-Nathalie Lebel, Olivier Bluteau, Alain Carrié, Jean-François Perregaux, Soumeya Bekri, Jean-Pierre Rabès, Antonio Gallo, Mathilde Varret

Published in

Journal of clinical lipidology. Sep 25, 2026. Epub Sep 25, 2026.

Abstract

Lysosomal acid lipase deficiency (LAL-D) is characterized by severe dyslipidemia, including elevated low-density lipoprotein (LDL) cholesterol, despite activation of sterol-responsive pathways.
We investigated whether altered receptor-mediated LDL catabolism may contribute to this phenotype.
Epstein-Barr virus (EBV)-transformed lymphoblastoid cells from a patient with cholesteryl ester storage disease (CESD) homozygous for the LIPA Exon 8 Splice-Junction Mutation were compared with cells from heterozygous carriers, heterozygous familial hypercholesterolemia patients, and controls. LAL activity was measured using a fluorometric assay. LDL receptor (LDLR) surface expression and LDL internalization were assessed by flow cytometry.
CESD cells displayed markedly reduced LAL activity together with modest but significant reductions in LDLR surface expression and LDL internalization. Under low-serum conditions, LDLR gene expression was also significantly lower in CESD cells than in controls.
These findings suggest that impaired LDLR-mediated LDL uptake may contribute to dyslipidemia in LAL-D, alongside previously reported alterations in lipoprotein production. Confirmation in additional patients and disease-relevant cellular models is required.

PMID:
42881040
Bibliographic data and abstract were imported from PubMed on 16 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.